Xenon Pharmaceuticals Inc.XENENASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending lower, below historical average, strong compound growth.
Left:
|
|
|
|

Operating cash flow minus capital expenditures

Latest
$-184.46M
↓ 176% below average
Average (9y)
$-66.77M
Historical baseline
Range
High:$-5.87M
Low:$-184.46M
CAGR
+29.0%
Consistent expansion
PeriodValueChange
2024$-184.46M-22.2%
2023$-150.94M-49.0%
2022$-101.32M-41.6%
2021$-71.55M-41.0%
2020$-50.76M-764.5%
2019$-5.87M+83.3%
2018$-35.23M-21.3%
2017$-29.04M-46.3%
2016$-19.85M-6.4%
2015$-18.65M-